Lumos Diagnostics Holdings Limited Price (LDX.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

463,193,771

(97.2352)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop read... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.02-0.069
  • Market Cap 16.47M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

  • ceo: Mr. Douglas Ward
  • IPO Date: July, 05, 2021
  • Country: AU
  • Currency: AUD
  • Headquaters: Melbourne, VIC
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation